Genetic Causes of Cerebral Palsy: When CP Isn’t Caused by Birth Injury

For decades, parents of children with cerebral palsy were told that the diagnosis almost always traces to perinatal brain injury, especially HIE. Recent research has substantially revised that picture. A growing body of evidence shows that a meaningful proportion of CP cases have identifiable genetic causes, and that genetic testing is increasingly part of a thorough CP workup. This is a real shift in how the field thinks about CP, and parents deserve an honest explanation rather than the simpler narrative of “all CP comes from birth injury.” This guide walks through what the research actually shows, when genetic testing is recommended, what it can find, and what families should know about the relationship between birth events and genetic causes.

How the Field’s Understanding Has Changed

The traditional view of cerebral palsy emphasized perinatal injury, particularly HIE, as the dominant cause. Older estimates suggested that genetic causes accounted for only a small percentage of CP cases. Two factors have changed this picture:

• Better genetic testing. Whole-exome sequencing and chromosomal microarrays now detect genetic causes that were invisible 20 years ago.
• Better criteria for attributing CP to perinatal injury. The 2014 ACOG/AAP report on neonatal encephalopathy clarified that documented intrapartum events, characteristic MRI findings, and other criteria are needed to attribute CP to perinatal injury. Many cases that were previously assumed to have a perinatal cause did not actually meet these criteria.

The result: more CP cases are now recognized to have other causes, including genetic ones. The 2021 MacLennan paper in Annals of Neurology was a landmark consolidation of this evidence.

How Common Is a Genetic Cause?

Estimates vary by study, by population, and by which CP cases were included. Modern comprehensive genetic testing finds an identifiable genetic cause in approximately 14 to 32 percent of CP cases:

The takeaway: when no clear perinatal cause is documented, genetic causes are common enough that testing should be part of the workup. When a clear perinatal cause is documented (with characteristic MRI findings), genetic causes are less likely but not impossible.

What Kinds of Genetic Findings Are Seen?

Several categories of genetic causes have been identified in CP:

When Genetic Testing Is Recommended

Genetic testing is not yet standard for every child with CP, but several clinical situations strongly suggest considering it:

• No clear perinatal cause. Normal cord blood gases, normal Apgars, no documented sentinel event, and no characteristic HIE MRI pattern.
• Brain MRI normal or atypical. CP without typical injury patterns on imaging.
• Atypical features. Dysmorphic appearance, seizures with unusual semiology, or other organ involvement.
• Family history. Other family members with similar neurological conditions.
• Consanguineous parents. Increases the prior probability of recessive genetic conditions.
• Ataxic CP or unusual CP subtype. Higher rates of underlying genetic causes.
• Diagnostic uncertainty. When clinicians are unsure whether the condition is truly non-progressive, or when they suspect a different diagnosis.

The decision to pursue testing is typically made by a pediatric neurologist, geneticist, or developmental pediatrician, often after discussion with the family about benefits, costs, and possible findings.

What Genetic Testing Actually Looks Like

For CP workup, the standard tests are:

Testing typically requires a blood sample (or sometimes a saliva sample). Results can take weeks to months. Insurance coverage varies; many clinical microarray and exome tests are covered when ordered with a clear medical indication.

What a Genetic Diagnosis Means for Families

Identifying a genetic cause changes several things:

• Recurrence risk in future pregnancies. De novo mutations typically carry a low recurrence risk. Inherited conditions can carry recurrence risks of 25 percent (autosomal recessive) or 50 percent (autosomal dominant) or higher in some patterns.
• Risk to other family members. Some inherited conditions affect siblings or extended family members; a diagnosis may indicate testing for them.
• Targeted screening. Some genetic conditions affect more than the brain. Identification can prompt screening for cardiac, renal, ophthalmologic, or other involvement.
• Targeted treatments. A small but growing number of genetic conditions have specific treatments. Identification may open new options.
• Connection to community. Many genetic conditions have foundation- or family-led support groups that provide both information and connection.
• Validation and explanation. For many families, simply knowing the cause provides important closure, regardless of whether treatment changes.

How a genetic finding interacts with the birth-injury question

This is the part that often confuses families. A genetic diagnosis does not always mean birth events were irrelevant. Several scenarios are possible:

• Pure genetic cause. The CP would have occurred regardless of delivery events. Birth events were unrelated.
• Pure birth-injury cause. A clear perinatal event with characteristic MRI findings. Genetic factors did not contribute.
• Combined effect. A genetic predisposition made the brain more vulnerable, and perinatal stress that another baby would have tolerated produced injury. Both factors mattered.
• Genetic finding of uncertain significance. A variant is identified, but its contribution to the CP is unclear.

Distinguishing these scenarios requires careful clinical correlation: timing and nature of any perinatal event, MRI findings, the specific genetic variant identified, and family history. A pediatric neurologist or geneticist can usually help families understand which scenario fits best.

Why This Matters Practically

Treatments and supports for CP do not depend on whether the cause is genetic or perinatal. Children with CP from any cause benefit from the same physical therapy, occupational therapy, speech therapy, equipment, and educational accommodations. The key practical implications of a genetic diagnosis are family planning, screening for associated conditions, and access to condition-specific communities and (occasionally) targeted therapies.

For families pursuing legal review of perinatal events, a genetic finding can change the picture. If a definitive genetic cause is identified, the case for perinatal injury as the primary cause may be undermined. If a genetic predisposition is identified but a clear sentinel event also occurred, both factors may matter. An honest review considers both possibilities.

What to ask your team about genetic testing

Useful questions when considering or interpreting genetic testing for CP: Has my child had genetic testing, and if so, what kind? Was a chromosomal microarray done? Was whole-exome or whole-genome sequencing done? Was a trio analysis performed (comparing my child to both parents)? Were any variants identified, and how were they classified (pathogenic, likely pathogenic, variant of uncertain significance, benign)? Has a clinical geneticist or genetic counselor reviewed the findings with us? What is the recurrence risk for future pregnancies based on what we know? Are there associated conditions we should be screening for? Bringing these questions to your pediatric neurology or genetics appointment helps ensure nothing is missed.

What classification of variants actually means

Genetic test reports use a standardized classification developed by the American College of Medical Genetics. The categories you may see are: pathogenic (clearly disease-causing), likely pathogenic (highly probable but not certain), variant of uncertain significance (VUS) (cannot yet be classified as either), likely benign, and benign. A VUS is the category families find most confusing. It does not mean the variant causes the condition; it does not mean it doesn’t. As more cases are reported and as research advances, VUSes are sometimes reclassified upward (to pathogenic) or downward (to benign) over time. Families with a VUS finding can ask their genetics team to flag the variant for periodic reanalysis. A pathogenic or likely pathogenic finding in a gene known to cause a CP-like phenotype is the most actionable result.

Related reading for parents

• Conditions that mimic cerebral palsy: differential diagnosis parents should know
• Ataxic cerebral palsy: understanding balance and coordination challenges
• Mixed cerebral palsy: when a child has symptoms of more than one CP type
• MACS, CFCS, and EDACS: the CP classification systems beyond GMFCS
• Neonatal encephalopathy vs HIE: understanding the terminology doctors use